Picture of Diaceutics logo

DXRX Diaceutics Share Price

0.000.00%
gb flag iconLast trade - 00:00
IndustrialsAdventurousSmall CapFalling Star

Momentum

Relative Strength (%)
1m-9.32%
3m-20.81%
6m-30.56%
1yr-28.45%
Volume Change (%)
10d/3m+62.44%
Price vs... (%)
52w High-38.23%
50d MA-5.17%
200d MA-20.79%

Growth & Value

12m Forecast RollingIndustryMarket
PE Ratio (f)25.05
PEG Ratio (f)0.61
EPS Growth (f)69.76%
Dividend Yield (f)n/a
Valuation (ttm)IndustryMarket
Price to Book Value1.56
Price to Tang. Book2.38
Price to Free Cashflown/a
Price to Sales4.11
EV to EBITDA16.76

Shareholder Activity

TypeBuy / Hold / Sell
Institutions
Directors
Community

Guru Screens

Quality

NameIndustryMarket
Return on Capital0.04%
Return on Equity0.32%
Operating Margin0.12%

Financial Summary

Year End 31st DecUnit201720182019202020212022E2023ECAGR / Avg
Total Revenue£m7.3710.3713.4412.713.9416.5320.824.89%
Operating Profitm
Net Profitm
EPS Reported
Diluted Normalised EPS
EPS Growth%-11.27+17.63+105.17-67.78-10.93+183.03+66.43n/a
PE Ratiox
PEG
Profitability
Operating Margin%
ROA%
ROCE%
ROE%
Cashflow
Op. Cashflow ps
Capex ps
Free Cashflow ps
Dividends
Dividend ps
Dividend Growth%
Dividend Yield%
Dividend Coverx
Balance Sheet
Cash etcm
Working Capitalm
NFAm
Net Debtm
Book Valuem
Diluted Weighted Average Sharesm
Book Value ps

Health Trend(F-Score)

12345678910

Bankruptcy Score(Z-Score)

Distress
Cautious
Safe

Earnings Manipulation Risk(M-Score)

Other Ratios

Leverage (ttm)Total- Intang+ Pension
Gross Gearing
Net Gearing
Cash / Assets

Recent History

Latest interim period vs. prior periodIndustryMarket
Sales Growth
EPS Growth
3yr Compound Annual Growth RateIndustryMarket
Sales CAGR
EPS CAGR
DPS CAGR

Graphical History

Revenue
Blurred out image of Revenue chart
Net Income
Blurred out image of Net Income chart
Normalised EPS
Blurred out image of Normalised EPS chart
PE Ratio Range
Blurred out image of PE Ratio Range chart
Dividend Yield Range
Blurred out image of Dividend Yield Range chart

Analyst Forecasts

Price target
( price)
31st Dec 202231st Dec 2023
Est. Long Term Growth Rate: Net Profit
()
EPS
()
DPS
()
Net Profit
()
EPS
()
DPS
()
Consensus Estimate
1m Change
3m Change

Analyst Consensus

Strong SellSellHoldBuyStrong Buy

EPS 2022 / 2023

Blurred out image of Diaceutics EPS forecast chart

Profile Summary

Diaceutics PLC is a diagnostic commercialization company. The principal activity of the Company is data analytics and implementation services. The Company is engaged in research and development activities in drug development science, testing data and software platform development. The Company's implementation services include test standardization, test quality assessment, test report optimization, laboratory tech support, test access and reimbursement, laboratory training & educational resources. The Company provides the pharmaceutical companies with an end-to-end solution for the launch of precision medicine diagnostics enabled by DXRX The Diagnostic Network. Its DXRX Data solutions provides unrivalled access to multiple pipelines of real-world diagnostic testing data from a global network of laboratories. Its DXRX implementation services uses a range of industry service providers in precision medicine diagnostics to execute development and commercialization strategies at local level.

Directors

    Last Annual
    December 31st, 2021
    Last Interim
    June 30th, 2022
    Incorporated
    May 17th, 2005
    Public Since
    March 21st, 2019
    No. of Employees
    123
    Sector
    Professional & Commercial Services
    Industry
    Industrials
    Exchange
    gb flag iconLondon Stock Exchange
    Shares in Issue
    84,472,431

    DXRX Share Price Performance

    Upcoming Events for DXRX

    Full Year 2022 Diaceutics PLC Earnings Release

    Diaceutics PLC Annual Shareholders Meeting

    Similar to DXRX

    Picture of ADVFN logo

    ADVFN

    gb flag iconLondon Stock Exchange

    Picture of Alteration Earth logo

    Alteration Earth

    gb flag iconLondon Stock Exchange

    Picture of Andrews Sykes logo

    Andrews Sykes

    gb flag iconLondon Stock Exchange

    Picture of Anexo logo

    Anexo

    gb flag iconLondon Stock Exchange

    FAQ

    Or unlock with your email

    Or unlock with your email